title: Pseudotumor cerebri associated with cyclosporine use in severe atopic dermatitis.
abstract: Cyclosporine use can cause neurologic complications in 0.5% to 35% of cases, although the appearance of pseudotumor cerebri (PC) is exceptional. PC secondary to the use of cyclosporine is described mainly in individuals who have received a bone marrow transplant. We report the first case, to our knowledge, of PC secondary to the use of cyclosporine in a child with severe atopic dermatitis, with satisfactory resolution and without vision sequelae.
authors: Department of Dermatology and Venereology, Virgen de las Nieves Hospital, Granada, Spain.
authors: Gonzalo
authors: G
authors: Blasco Morente
authors: Jesús
authors: J
authors: Tercedor Sánchez
authors: Cristina
authors: C
authors: Garrido Colmenero
authors: Eliseo
authors: E
authors: Martínez García
authors: Antonio
authors: A
authors: Molina-Carballo
mesh_terms: D002648:Child; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D011559:Pseudotumor Cerebri / Q000139:chemically induced* / Q000503:physiopathology; D018570:Risk Assessment; D012720:Severity of Illness Index; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine